| F & G Group, Inc. | |
|
16349 Valley Oaks Estates Ct Chesterfield MO 63005-7039 | |
| (314) 604-9959 | |
| Not Available |
| Full Name | F & G Group, Inc. |
|---|---|
| Speciality | Internal Medicine |
| Location | 16349 Valley Oaks Estates Ct, Chesterfield, Missouri |
| Authorized Official Name and Position | Baolin Fan (OWNER) |
| Authorized Official Contact | 3146049959 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| F & G Group, Inc. 16349 Valley Oaks Estates Ct Chesterfield MO 63005-7039 Ph: () - | F & G Group, Inc. 16349 Valley Oaks Estates Ct Chesterfield MO 63005-7039 Ph: (314) 604-9959 |
| NPI Number | 1164628186 |
|---|---|
| Provider Enumeration Date | 06/26/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 4688769904 |
|---|---|
| Medicare Enrollment ID | O20071002000453 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
The Rosalind Franklin Institute today launched an ambitious new project to build the world's most advanced real-time high-speed video camera, the key to understanding new techniques that use light and sound to treat some of the most lethal forms of cancer.
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164628186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 110986 (Missouri) | Primary |
| Provider Name | Baolin Fan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568568897 PECOS PAC ID: 7113972837 Enrollment ID: I20050316000028 |
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
The Rosalind Franklin Institute today launched an ambitious new project to build the world's most advanced real-time high-speed video camera, the key to understanding new techniques that use light and sound to treat some of the most lethal forms of cancer.
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
› Verified 6 days ago
News Archive
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males. For pets, the technique could be an alternative to castration and adverse effects of hormone administration.
The Rosalind Franklin Institute today launched an ambitious new project to build the world's most advanced real-time high-speed video camera, the key to understanding new techniques that use light and sound to treat some of the most lethal forms of cancer.
Pfizer Inc. today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has extended the expiration date of its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
› Verified 6 days ago
Maryland Medical Group Ltd Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 S Woods Mill Rd, Suite 350n, Chesterfield, MO 63017 Phone: 314-205-6557 | |
Physician Affiliates Of St. Luke's Medical Group, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 Saint Lukes Center Dr, Chesterfield, MO 63017 Phone: 314-576-2475 | |
Digestive Consultants Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 S Woods Mill Rd Ste 410, Chesterfield, MO 63017 Phone: 636-685-7795 Fax: 314-590-5959 | |
Wuca Woods Mill Pediatrics, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 226 S Woods Mill Rd, Suite 36w, Chesterfield, MO 63017 Phone: 314-453-9666 | |
Palm Valley Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1095 Nooning Tree Dr, Chesterfield, MO 63017 Phone: 314-800-6980 | |
Diagnostic Internists, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, 410 S, Chesterfield, MO 63017 Phone: 314-878-7220 Fax: 314-878-0047 | |
County Internal Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Suite 370 South, Chesterfield, MO 63017 Phone: 314-628-9994 |